Uganda’s Minister of Science, Technology, and Innovation, Dr. Monica Musenero, has announced a major government initiative to begin producing vaccines for the Monkeypox virus, commonly known as Mpox, which is currently affecting several African nations. The plan was revealed during her meeting with the Parliamentary Presidential Affairs Committee on October 1, 2024.
Dr. Musenero highlighted Uganda’s collaboration with both local and international experts in developing diagnostics, vaccines, and treatments for Mpox, which has been classified as a public health threat. “We are formulating a strategy to develop diagnostics, vaccines, and treatments for Monkeypox,” Musenero stated, emphasizing the growing need for an African response to the virus.
Mpox, a viral infection causing painful rashes, fever, and swollen lymph nodes, is primarily spread through close contact with infected individuals. While most people recover, some cases can become severe. The World Health Organization (WHO) recommends several vaccines, including MVA-BN, LC16, and ACAM2000, to offer significant protection against the virus.
Musenero also defended Uganda’s efforts in vaccine research, citing financial success from the country’s COVID-19 response. Despite skepticism, Uganda earned UGX 140 billion through Polymerase Chain Reaction (PCR) testing, positioning the nation as a continental leader in scientific research.
In a bid to address air quality issues, Musenero shared plans to phase out fuel-powered motorcycles in Kampala, replacing them with electric ones. This effort aims to reduce pollution and improve air conditions in the capital city. “We are working with the private sector to transition motorcycles from fuel to electric, leading the charge in the region,” she added.
However, the Minister faced scrutiny over the Banana Industrial Development initiative. Bukanga County MP Stephen Kangwagye questioned the project’s low output despite claims of significant tax contributions. “The situation on the ground does not match the positive image you paint. What products are you selling, and to whom?” Kangwagye asked.
Kangwagye also suggested Uganda reduce reliance on imported lab mice, proposing local rats be used for scientific research. “Why import lab mice from Germany when we have local rats that could serve the same purpose?” he inquired.
The debate reflects the complex challenges and opportunities facing Uganda’s scientific and economic initiatives as the country navigates public health crises and developmental projects.
